@article{cdfb0c154af34e0fb56f8c581e344ee3,
title = "Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma",
author = "N. Shah and Thall, {P. F.} and Fox, {P. S.} and Q. Bashir and Shah, {J. J.} and S. Parmar and P. Lin and P. Kebriaei and Y. Nieto and Popat, {U. R.} and Hosing, {C. M.} and A. Cornelison and Shpall, {E. J.} and Orlowski, {R. Z.} and Champlin, {R. E.} and Qazilbash, {M. H.}",
note = "Funding Information: We are indebted to all patients and contributing doctors. This study was supported by grants 110284, 110287, 110292 and 111267 from Deutsche Krebshilfe; grant DJCLS R13/14 from the Deutsche Jos{\'e} Carreras Leuk{\"a}mie-Stiftung eV; the German Federal Ministry of Education and Research grant 01EO0802 (IFB-Tx); DFG grant HE 5240/5-1 and HE 5240/6-1; and grants from Dieter-Schlag Stiftung. Funding Information: Drs N Shah, Bashir, JJ Shah, Hosing and Orlowski receive research funding from Celgene. Drs N Shah, JJ Shah and Orlowski have served on Celgene Advisory Boards.",
year = "2015",
month = sep,
day = "4",
doi = "10.1038/leu.2015.54",
language = "English (US)",
volume = "29",
pages = "1945--1948",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "9",
}